MY REWARDS INTERNATIONAL LIMITED(MRI)

Klevo Rewards Limited announced on 12 September 2025 a pro-rata non-renounceable entitlement issue of one share for every two shares held at an issue price of $0.009, aiming to raise approximately $4,117,276.

The company's Entitlement Offer closed on 15 October 2025, raising approximately $1,771,799 from eligible shareholders, or 43% of shares offered.

Securities of the company have been suspended for over three months, as detailed in the table unfiled periodic reports, deadlines for the oldest report, and two-year plans for resuming trade. Failure to meet these deadlines leads to removal from the official list after the specified trading day.

The company's entitlement issue offers eligible shareholders one share for every two held at $0.009, raising approximately $4.1 million. The closing date is extended to 15 October 2025, with key dates outlined for various processes.

The company has re-lodged its Annual Report for the year ended 30 June 2025 due to the correction of two typographical errors found after the original submission on 30 September 2025. The first error related to the Working Capital Amount in the Going Concern Note, which incorrectly referred to current liabilities instead of the deficiency in working capital. The second error was a mistyped net liabilities amount also in the Going Concern note. No other changes were made to the Annual Report.

The company releases an updated version of its annual report to shareholders.

The company lodges its full year statutory accounts, appendix 4G, and corporate governance statement.

The company releases a supplementary prospectus, dated 25 September 2025, accompanies the prospectus issued by Klevo Rewards Limited on 12 September 2025. It was lodged with ASIC, which does not take responsibility for its contents. While most details remain unchanged, the supplementary document prevails in case of conflicts with the original prospectus. It is available in hard copy or online at the Company's website and should be read in full; professional advice is recommended for any uncertainties.

Klevo Rewards Limited has received an extension from the ASX for its automatic removal from the Official List, now set for 17 November 2025. This follows a suspension from quotation that began on 2 October 2023, which would have resulted in removal on 2 October 2025. The extension allows the Company to finalize an entitlement offer for shares to raise approximately $4.1 million, aimed at satisfying ASX's reinstatement conditions for resuming trading. The new deadline for meeting these conditions is also 17 November 2025.

The company has completed the dispatch of its prospectus for a pro-rata non-renounceable entitlement issue, offering one fully paid ordinary share for every two shares held, at an issue price of $0.009 per share, aiming to raise up to $4,117,276. The prospectus, lodged with ASIC and ASX on 12 September 2025, contains further details on how to accept the offer and associated investment risks. Eligible shareholders must submit their applications by 5:00pm (AEST) on 1 October 2025, following the instructions on their Entitlement and Acceptance Form.

The company releases its application for quotation of securities.

The company releases the results of its annual general meeting.

The company releases its entitlement offer prospectus for a pro-rata non-renounceable entitlement issue of one share for every two Shares held by those shareholders registered at the record date at an issue price of $0.009 per share to raise up to $4,117,276.

The company is aiming to raise $4,117,276 through a pro rata non-renounceable entitlement offer, offering one fully paid ordinary share for every two shares held by eligible shareholders, with an underwritten amount of $3.4 million.

The company releases its application for quotation of securities.

The company releases its application for quotation of securities.

The company lodges its preliminary final report.

The company will hold its annual general meeting virtually on 19 September 2025 at 10:00 am (AEST).

The company has been confirmed by ASX to reinstate its securities to official quotation. The company plans to convert $2.2 million of liabilities into equity and partially underwrite a non-renounceable entitlement offer to raise $3.98 million.

The company lodges its notice of cessation of securities.

The company releases its application for quotation of securities.

The company has developed the 'KLEVO Platform', a blockchain-based rewards and loyalty platform, following its acquisition of Fly Wallet and completion of the Klevo Rewards Pilot program. The platform will manage all reward and loyalty program activities, including onboarding, and will be available on iOS and Android, focusing on B2B and employee reward programs.

The company releases its Quarterly Activities/Appendix 4C Cash Flow Report.

Entities with securities suspended for over three months must lodge periodic reports, meet a 1 year deadline for the oldest outstanding report, and execute plans for resuming trading to ASX's satisfaction. Failure to meet deadlines results in removal from the official list.

The company has received confirmation from the Australian Securities Exchange that it can reinstate MRI's securities to official quotation, subject to certain reinstatement conditions. ASX retains the absolute discretion to not reinstate MRI securities to quotation at any time.

The company lodges its application for quotation of securities.

The company releases its quarterly activities/appendix 4C cash flow report.

The company lodges its application for quotation of securities.

The company has acquired Fly Wallet, a company specializing in creating innovative loyalty and rewards wallet programs, providing secure, multicurrency solutions for businesses.

The company releases its application for quotation of securities.

Entities that have been suspended for more than three months due to their unfiled periodic reports, along with the oldest overdue report deadline and their two-year deadline for trading plans, will be removed from the official list if these conditions are not fulfilled.

The company lodges its application for quotation of securities.

The company lodges its half year accounts.

The company releases its Annual Report to shareholders for 2024.

The company releases its Quarterly Activities/Appendix 4C Cash Flow Report.

The entities suspended for over three months failed periodic reports, the oldest outstanding report deadline, and their 2 year deadline for trading plans. If not met, they will be removed from the official list, usually after the first trading day.

The company releases its Half Year Accounts.

The company has appointed Connect National Audit Pty Ltd as its new auditor, following RSM Australia Partners' resignation. The appointment will be ratified at the company's 2024 Annual General Meeting.

The company lodges its application for quotation of securities.

The company has received $1.44 million from sophisticated investors, with 200,000,000 shares. The company is finalizing its interim financial reports and Annual Report for FY 2024. The company is negotiating repayment of outstanding loan amounts with iGoDirect, which led to the appointment of a receiver. Mr. George Minas has been appointed as legal counsel and is a shareholder of Etimoney Pty Ltd.

The company has reached a settlement with Frankly Agency Pty Ltd regarding the Frankly Dispute, as disclosed in its Annual Report and subsequent ASX announcements.

The company has finalized negotiations with Fly Wallet to acquire 100% of Etimoney's shares, securing its position to create a Global Rewards and Loyalty Program. Additionally, My Rewards secures a $1.3 million firm commitment from sophisticated investors.

The company releases its Quarterly Activities/Appendix 4C Cash Flow Report.

The company releases its notice of cessation of securities.

The company releases its application for quotation of securities.

ASX releases a notice regarding long-term suspended entities. The company's securities have been suspended for more than 3 months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

The company releases a reissued Annual Report for FY 2023.

The Company has entered into an additional Software Licence Deed and Deed of Acknowledgement for a deemed consideration of $275,000 which will see the outstanding loan amount reduced to $145,657.48 plus interest. The outstanding loan amount of $145,657.48 is now due and the Company is negotiating a payment extension.

The company releases a notice of application for quotation of securities.

The company has entered into a Heads of Agreement to acquire Fly Wallet Pty Ltd, securing My Rewards' position to create a Global Rewards & loyalty program. The acquisition is conditional on regulatory and ASX approvals and an independent valuation of Fly Wallet. The consideration payable is $2 million in cash and MRI shares, with no change to MRI's Board of Directors.

The company lodges its application for quotation of securities.

The company lodges its preliminary final report.

The company releases the results of its meeting.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

Notice is given that the Meeting will be held at: 10:00 am (Melbourne time) on Tuesday 27 August 2024. It's a Virtual Meeting through https://web.lumiagm.com/369700412.

The company releases a notice of application for quotation of securities.

The company releases a notice of proposed issue of securities.

The Company has finalised the Side Deed with iGoDirect Group to facilitate completion occurring under the Asset Sale Agreement. As at the date of this announcement, 19 out of 20 Key Customer Contracts have been successfully assigned resulting in a further reduction of the loan by $76,477.66. The last outstanding Key Customer Contract was declined by the customer to be assigned. iGoDirect has agreed for MRI to find a substitute customer and effectively assign the contract for a similar value as the Unassigned Contract on or before 12th September 2024 to further reduce the loan by $11,580.47

$1million funding committed to be drawn down in tranches. Issue Price - $0.009. Shares under the placement to be issued to Abreco Enterprises Pty Ltd (Abreco). Funds to be applied towards working capital for the Company.

The securities of the company have been suspended for more than three months. If an entity does not meet the 1 or 2 year deadlines, it will be removed from the official list. The removal will usually take effect from the open of trading on the first trading day after the deadline date.

My Rewards International Limited and iGoDirect Group Pty Ltd have agreed to extend the Post Completion Subsequent End Date from today (28th June 2024) to Friday 11 July 2024 to deliver remaining outstanding requirements under the Side Deed entered into by both parties on 14 May 2024.

The company responds to the query of asx-general-aware, referring to the letter dated 13th May 2024, providing a response to each of the questions.

The company has signed a Side Deed with iGoDirect Group Pty Ltd to facilitate completion under the Asset Sale Agreement. The company and iGoDirect have been discussing how to handle a few of the 20 client employee/member benefits agreements that require additional time to obtain consents. The Side Deed confirms completion on or around 14 May 2024, with 17 out of 20 Key Customer Contracts acknowledged and confirmed. An additional 45 days are provided from the Completion Date to procure the assignment of the remaining 3 Key Customer Contracts and attend to other conditions subsequent. The company is confident that it will be able to obtain the assignment of the remaining 3 Key Customer Contracts by the Condition Subsequent End Date, resulting in no material change to the Asset Sale Agreement. The balance of the loan principal of $401,500 plus interest owing under the Loan Facility Agreement is due on 14 September 2024.

The company has been restricted the Australian Securities and Investments Corporation from using transaction-specific disclosure exceptions under s713(6) of the Corporations Act 2001(Cth) until May 2, 2025. This means MRI cannot rely on reduced disclosure rules under s713 and must issue a full prospectus to raise funds from certain investors, without affecting MRI's operations and business.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company issues a response to ASX Aware Query.

The Company has entered into a suite of agreements with iGoDirect Group Pty Ltd and/or its nominee which will see the Company reduce its loan facility from iGoDirect by $725,000.00.

The Company and iGoDirect Group has agreed to extend the due date of the loan to the 9th of April 2024. Further to the announcement dated 8th April 2024, MRI is finalising discussions with iGoDirect in relation to the loan and expects to provide a formal update by 9th April 2024.

My Rewards International Limited wishes to provide a further update on the iGoDirect Group Pty Ltd $1 million loan as announced on 20th November 2023. The Company and iGoDirect Group has agreed to extend the due date of the loan to the 8th of April 2024. MRI is continuing discussions with iGoDirect in relation to the loan and expects to provide a formal update by 8th April 2024.

The Company and iGoDirect Group has agreed to extend the due date of the loan to the 5th of April 2024. MRI is currently in ongoing discussions with iGoDirect in relation to the loan and expects to provide a formal update by 5th April 2024.

The Company and iGoDirect Group has agreed to extend the due date of the loan to the 5th of April 2024. MRI is currently in ongoing discussions with iGoDirect in relation to the loan and expects to provide a formal update by 5th April 2024.

The company releases a notice of application for quotation of securities

The directors of MRI have re-opened the FY 2023 annual accounts in order for the auditors, RSM, to review requested additional information and supporting documentation. The company is in the final stages of compiling the information and expects to provide RSM with the information by 15 March 2024. RSM will then proceed to review the information and work towards providing an updated audited set of accounts for the FY2023. The reason the directors have re-opened the accounts and following the above process is to seek an audit opinion for FY 2023 annual accounts. The Half-year 31 December 2023 will be finalised after the FY2023 Annual Report has been re-lodged with the ASX and ASIC. Until the FY 2023 annual accounts are finalised, the company is not in a position to finalise a set of accounts for the Interim financial report for the half-year 31 December 2023 as the opening balances for the period may be impacted based on the view of the auditors for FY 2023 annual accounts.

The company releases a notice of application for quotation of securities.

28,707,000 fully paid ordinary shares will be released from escrow on 15 February 2024. An Appendix 2A will be lodged with the ASX to request the quotation of these shares

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company releases the results of its Annual General Meeting.

The company releases a Company Presentation.

The company releases the Chairman's Address to Shareholders.

The company issues a response to Third ASX Aware Letter.

The company's AGM will be held at 10:00 am (Melbourne time) on Wednesday 20 December 2023 online at https://web.lumiagm.com/373634963.

The Company has entered into a A$1 million loan agreement with iGoDirect Group Pty Ltd which will support the Company for the medium term.

The company issues a response to further ASX Query Letter.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The securities of My Rewards International Limited were suspended from quotation on 2 October 2023 under Listing Rule 17.3. MRI's Annual Report for the financial year ended 30 June 2023 contained a disclaimer of opinion by MRI's auditors in respect of MRI's financial report and remuneration report. ASX determined that MRI's financial condition was not adequate to warrant the continued quotation of its securities and therefore not in compliance with Listing Rule 12.2. On 16 October 2023, ASX required MRI to provide responses to ASX's initial queries relating to MRI's Annual Report for release to the market which are set out in the announcement entitled "˜Response to ASX Query Letter' dated 27 October 2023 and lodged on the ASX Market Announcements Platform today, 30 October 2023. Until such time as MRI rectifies to ASX's satisfaction the disclaimed audit opinions contained in its Annual Report and ASX is otherwise satisfied MRI is in compliance with the ASX Listing Rules, including Listing Rule 12.2, MRI's securities will continue to be suspended from quotation pursuant to Listing Rule 17.3.

The company issues a response to ASX Query Letter.

The securities of My Rewards International Limited will be suspended from quotation immediately in accordance with Listing Rule 17.3. ASX has determined that MRI's financial condition is not adequate to warrant the continued quotation of its securities and therefore is in breach of Listing Rule 12.2. The suspension will continue until MRI is able to demonstrate compliance with Listing Rule 12.2.

listed entity carried for record purposes only